loading

Finanzdaten der Exact Sciences Corp.-Aktie (EXAS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
2.95%
646.88
628.34 622.09 602.45 553.00
Cost Of Revenue
1.98%
171.87
168.53 156.99 156.87 147.15
Gross Profit
3.31%
475.02
459.81 465.10 445.58 405.84
Operating Expenses
19.85%
542.86
452.96 542.03 522.67 524.73
Benefits Costs and Expenses
11.15%
697.26
627.29 702.01 674.94 682.92
Costs And Expenses
3.98%
721.13
693.52 699.02 679.54 671.88
Operating Income/Loss
1,091%
-67.84
6.849 -76.93 -77.09 -118.88
Nonoperating Income/Loss
400.81%
17.46
-5.806 -2.99 4.597 -11.04
Income/Loss From Continuing Operations Before Tax
4,930%
-50.38
1.043 -79.92 -72.49 -129.93
Income Tax Expense/Benefit
344.98%
-0.61
0.249 1.107 1.657 -2.182
Income/Loss From Continuing Operations After Tax
6,368%
-49.77
0.794 -81.03 -74.15 -127.75
Net Income/Loss
6,368%
-49.77
0.794 -81.03 -74.15 -127.75
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.82%
0.327
180.65 180.20 178.57 0.416
Diluted Average Shares
99.82%
0.327
184.07 180.20 178.57 0.416
Basic Earnings Per Share
-0.27
- -0.45 -0.42 -0.72
Diluted Earnings Per Share
-0.27
- -0.45 -0.42 -0.72
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$111.07
price down icon 2.96%
diagnostics_research LH
$210.59
price down icon 1.19%
diagnostics_research WAT
$355.95
price down icon 1.26%
$314.72
price down icon 0.35%
diagnostics_research MTD
$1,522.75
price down icon 0.51%
diagnostics_research IQV
$231.18
price down icon 1.63%
Kapitalisierung:     |  Volumen (24h):